Merge Healthcare Incorporated. (MRGE) - NASDAQ
  • Aug. 6, 2015, 12:43 PM
    | Aug. 6, 2015, 12:43 PM | 100 Comments
  • Aug. 6, 2015, 9:38 AM
    • IBM is buying Merge Healthcare (NASDAQ:MRGE), a top provider of software for managing and processing medical images, for $1B in cash after factoring net debt, or $7.13/share. The price represents a 32% premium to Merge's Wednesday close. The deal is expected to close later this year.
    • Merge's software is said to be "used at more than 7,500 U.S. healthcare sites, as well as most of the world's leading clinical research institutes and pharmaceutical firms." IBM plans to integrate Merge with its recently-launched Watson Health unit, with the goal of providing image analytics that leverage Watson's A.I./deep learning technology.
    • Big Blue: "IBM plans to leverage the Watson Health Cloud to analyze and cross-reference medical images against a deep trove of lab results, electronic health records, genomic tests, clinical studies and other health-related data sources, already representing 315 billion data points and 90 million unique records.  Merge's clients could compare new medical images with a patient's image history as well as populations of similar patients to detect changes and anomalies."
    • In April, when Watson Health was launched, IBM announced it's buying cloud patient data analysis software firm Phytel and clinical database/healthcare analytics app provider Explorys. The company also announced healthcare-related partnerships with Apple, Medtronic, and Johnson & Johnson.
    | Aug. 6, 2015, 9:38 AM | 7 Comments
  • Jul. 8, 2015, 5:41 PM
    | Jul. 8, 2015, 5:41 PM
  • Jun. 24, 2015, 10:18 AM
    • Topeka Capital has upgraded Merge Healthcare (NASDAQ:MRGE) to Buy, and set a $5.75 target.
    • It was only on April 27 that Topeka had downgraded the healthcare image-sharing software vendor to Hold, shortly before it posted mixed Q1 results. Shares had fallen 25% since the downgrade.
    | Jun. 24, 2015, 10:18 AM
  • Apr. 7, 2015, 5:36 PM
    • Top gainers, as of 5:15 p.m.: RGLS +8.8%. WG +8.7%. EVR +5.7%. RCAP +3.9%. HLX +2.9%.
    • Top losers, as of 5:15 p.m.: EPE -5.6%. MTDR -4.5%. PNR -4.1%. INFI -4.1%. MRGE -4.0%.
    | Apr. 7, 2015, 5:36 PM | 2 Comments
  • Feb. 26, 2015, 12:57 PM
    | Feb. 26, 2015, 12:57 PM | 7 Comments
  • Jun. 12, 2014, 5:36 PM
    | Jun. 12, 2014, 5:36 PM
  • Aug. 26, 2013, 8:34 AM
    • Shares of Merge Healthcare (MRGE) rise 5.4% premarket.
    • Chairman Michael Ferro, Jr. has resigned.
    • MRGE says Dennis Brown is the new chairman, effective immediately.
    • Ferro believes the company's "market position and long-term prospects" are not reflected in the current stock price despite MRGE's "very disappointing" Q2 results.
    • Ferro also says that while he has no immediate plans, he intends to pursue "ways to increase shareholder value, including, possibly, a going-private transaction." (PR)
    | Aug. 26, 2013, 8:34 AM
  • Aug. 20, 2013, 5:40 PM
    | Aug. 20, 2013, 5:40 PM | 2 Comments
  • Aug. 9, 2013, 12:46 PM
    | Aug. 9, 2013, 12:46 PM
  • Aug. 9, 2013, 9:58 AM
    • Merge Healthcare (MRGE -41.8%) is in free-fall, after releasing disappointing Q2 results.
    • The company attributes its results to "continued reluctance amongst large health systems to move forward with enterprise purchases."
    • Merge also announces the resignation of CEO Jeffery Surges; he will be replaced by Justin Dearborn, who has previously served as Merge's CEO and CFO, and most recently as President and CEO of Merge's DNA unit. (8K)
    • Merge is also appointing operations EVP Nancy Koenig to the newly-created position of COO, and giving her Surges' vacated board seat.
    • A silver lining: backlog in the clinical trials unit, for which revenue is 100% subscription-based, grew 28.7% Y/Y to $45.7M.
    | Aug. 9, 2013, 9:58 AM
  • Jul. 16, 2013, 5:39 PM
    After-hours top gainers, as of 5:15 p.m.: EXXI +14%. TRP +4%. FDML +3%. PKG +3%. SMRT +3%.
    After-hours top losers: ZAGG -15%. MSPD -5%. AXP -2%. IBKR -2%. MRGE -2%.
    | Jul. 16, 2013, 5:39 PM
  • Nov. 21, 2012, 5:39 PM
    After-hours top gainers, as of 5:15 p.m.: IMGN +7.1%. SHLD +4.2%. ARRY +3.4%. IDIX +3.0%. VRTX +2.5%
    After-hours top losers: MRGE -9.0%. CVGI -7.1%. GORO -6.6%. HW -6.3%. QLIK -4.5%.
    | Nov. 21, 2012, 5:39 PM | 2 Comments
  • Sep. 7, 2012, 12:40 PM

    Merge Healthcare (MRGE -4.2%) slips after announcing that its Board has hired Allen & Company to assist in exploring and evaluating a broad range of strategic alternatives , including a sale. Additionally, Dougherty cuts the shares to Neutral, saying its fundamentals are weakening and it's going to be difficult to determine a value for the company, much less predict the probability of any sale at all.

    | Sep. 7, 2012, 12:40 PM
  • Sep. 6, 2012, 9:14 AM

    Merge Healthcare (MRGE) +17.3% premarket after announcing its intention to explore strategic alternatives including a potential sale of the company or a business combination.

    | Sep. 6, 2012, 9:14 AM | 1 Comment
  • Jul. 31, 2012, 6:20 PM
    Merge Technologies (MRGE): Q2 EPS of $0.02 beats by $0.01. Revenue of $62.9M (+13% Y/Y) beats by $2.3M. Shares +8.1% AH.
    | Jul. 31, 2012, 6:20 PM
Company Description
Merge Healthcare Inc develops software solutions that facilitate the sharing of images to create a more effective and efficient electronic healthcare experience for patients and physicians.
Sector: Technology
Industry: Healthcare Information Services
Country: United States